| Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors DA Wainwright, AL Chang, M Dey, IV Balyasnikova, CK Kim, A Tobias, ... Clinical cancer research 20 (20), 5290-5301, 2014 | 601 | 2014 |
| IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival DA Wainwright, IV Balyasnikova, AL Chang, AU Ahmed, KS Moon, ... Clinical cancer research 18 (22), 6110-6121, 2012 | 445 | 2012 |
| Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy B Auffinger, AL Tobias, Y Han, G Lee, D Guo, M Dey, MS Lesniak, ... Cell Death & Differentiation 21 (7), 1119-1131, 2014 | 372 | 2014 |
| Multifunctional nanoparticles for brain tumor imaging and therapy Y Cheng, RA Morshed, B Auffinger, AL Tobias, MS Lesniak Advanced drug delivery reviews 66, 42-57, 2014 | 346 | 2014 |
| Blood‐brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging Y Cheng, Q Dai, RA Morshed, X Fan, ML Wegscheid, DA Wainwright, ... Small 10 (24), 5137-5150, 2014 | 271 | 2014 |
| Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors IV Balyasnikova, MS Prasol, SD Ferguson, Y Han, AU Ahmed, M Gutova, ... Molecular Therapy 22 (1), 140-148, 2014 | 127 | 2014 |
| The art of gene therapy for glioma: a review of the challenging road to the bedside A Tobias, A Ahmed, KS Moon, MS Lesniak Journal of Neurology, Neurosurgery & Psychiatry 84 (2), 213-222, 2013 | 121 | 2013 |
| A preclinical evaluation of neural stem cell–based cell carrier for targeted antiglioma oncolytic virotherapy AU Ahmed, B Thaci, AL Tobias, B Auffinger, L Zhang, Y Cheng, CK Kim, ... Journal of the National Cancer Institute 105 (13), 968-977, 2013 | 108 | 2013 |
| Dedifferentiation of glioma cells to glioma stem-like cells by therapeutic stress-induced HIF signaling in the recurrent GBM model G Lee, B Auffinger, D Guo, T Hasan, M Deheeger, AL Tobias, JY Kim, ... Molecular cancer therapeutics 15 (12), 3064-3076, 2016 | 104 | 2016 |
| Nanoparticle‐programmed self‐destructive neural stem cells for glioblastoma targeting and therapy Y Cheng, R Morshed, SH Cheng, A Tobias, B Auffinger, DA Wainwright, ... Small 9 (24), 4123-4129, 2013 | 97 | 2013 |
| Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma? B Auffinger, R Morshed, A Tobias, Y Cheng, AU Ahmed, MS Lesniak Oncotarget 4 (3), 378, 2013 | 92 | 2013 |
| Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model B Thaci, AU Ahmed, IV Ulasov, AL Tobias, Y Han, KS Aboody, ... Cancer gene therapy 19 (6), 431-442, 2012 | 92 | 2012 |
| The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma AL Tobias, B Thaci, B Auffinger, E Rincón, IV Balyasnikova, CK Kim, ... Stem cells translational medicine 2 (9), 655-666, 2013 | 89 | 2013 |
| Dendritic cell–based vaccines that utilize myeloid rather than plasmacytoid cells offer a superior survival advantage in malignant glioma M Dey, AL Chang, J Miska, DA Wainwright, AU Ahmed, IV Balyasnikova, ... The Journal of Immunology 195 (1), 367-376, 2015 | 60 | 2015 |
| Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma B Thaci, AU Ahmed, IV Ulasov, DA Wainwright, P Nigam, B Auffinger, ... Cancer gene therapy 21 (1), 38-44, 2014 | 38 | 2014 |
| N-acetylcysteine amide augments the therapeutic effect of neural stem cell-based antiglioma oncolytic virotherapy CK Kim, AU Ahmed, B Auffinger, IV Ulasov, AL Tobias, KS Moon, ... Molecular Therapy 21 (11), 2063-2073, 2013 | 29 | 2013 |
| MMP14 as a novel downstream target of VEGFR2 in migratory glioma-tropic neural stem cells NG Alexiades, B Auffinger, CK Kim, T Hasan, G Lee, M Deheeger, ... Stem cell research 15 (3), 598-607, 2015 | 19 | 2015 |
| Correction: Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors DA Wainwright, AL Chang, M Dey, IV Balyasnikova, CK Kim, A Tobias Clinical Cancer Research 21 (3), 662, 2015 | 1 | 2015 |
| Sc-02conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy B Auffinger, A Tobias, Y Han, G Lee, D Guo, M Dey, M Lesniak, A Ahmed Neuro-Oncology 16 (Suppl 5), v197, 2014 | 1 | 2014 |
| Gold nanoparticles as a drug delivery system for malignant brain tumors Y Cheng, Q Dai, R Morshed, Y Han, B Auffinger, D Wainwright, L Zhang, ... NEURO-ONCOLOGY 15, 39-40, 2013 | 1 | 2013 |
